Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Feb;3(1 Suppl 1):29–34. doi: 10.1111/j.1365-2125.1976.tb03709.x

The significance of drug interactions in the evaluation of psychotropic drugs.

R A Braithwaite
PMCID: PMC2958740  PMID: 973945

Full text

PDF
29

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexanderson B., Evans D. A., Sjöqvist F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J. 1969 Dec 27;4(5686):764–768. doi: 10.1136/bmj.4.5686.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asberg M., Crönholm B., Sjöqvist F., Tuck D. Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J. 1971 Aug 7;3(5770):331–334. doi: 10.1136/bmj.3.5770.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braithwaite R. A., Goulding R., Theano G., Bailey J., Coppen A. Plasma concentration of amitriptyline and clinical response. Lancet. 1972 Jun 17;1(7764):1297–1300. doi: 10.1016/s0140-6736(72)91031-8. [DOI] [PubMed] [Google Scholar]
  4. Breckenridge A., Orme M. Clinical implications of enzyme induction. Ann N Y Acad Sci. 1971 Jul 6;179:421–431. doi: 10.1111/j.1749-6632.1971.tb46919.x. [DOI] [PubMed] [Google Scholar]
  5. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  6. Curry S. H., D'Mello A., Mould G. P. Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Br J Pharmacol. 1971 Jul;42(3):403–411. doi: 10.1111/j.1476-5381.1971.tb07125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garrettson L. K., Perel J. M., Dayton P. G. Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. JAMA. 1969 Mar 17;207(11):2053–2056. [PubMed] [Google Scholar]
  8. Gram L. F., Overo K. F. Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br Med J. 1972 Feb 19;1(5798):463–465. doi: 10.1136/bmj.1.5798.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greenwood R. H., Prunty F. T., Silver J. Osteomalacia after prolonged glutethimide administration. Br Med J. 1973 Mar 17;1(5854):643–645. doi: 10.1136/bmj.1.5854.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hollister L. E., Curry S. H. Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions. Res Commun Chem Pathol Pharmacol. 1971 May;2(3):330–338. [PubMed] [Google Scholar]
  11. Johnson D. A. Treatment of depression in general practice. Br Med J. 1973 Apr 7;2(5857):18–20. doi: 10.1136/bmj.2.5857.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kragh-Sørensen P., Asberg M., Eggert-Hansen C. Plasma-nortriptyline levels in endogenous depression. Lancet. 1973 Jan 20;1(7795):113–115. doi: 10.1016/s0140-6736(73)90192-x. [DOI] [PubMed] [Google Scholar]
  13. Kupferberg H. J., Jeffery W., Hunninghake D. B. Effect of methylphenidate on plasma anticonvulsant levels. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):201–204. doi: 10.1002/cpt1972132201. [DOI] [PubMed] [Google Scholar]
  14. Meyer J. F., McAllister C. K., Goldberg L. I. Insidious and prolonged antagonism of guanethidine by amitriptyline. JAMA. 1970 Aug 31;213(9):1487–1488. [PubMed] [Google Scholar]
  15. Mitchell J. R., Arias L., Oates J. A. Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA. 1967 Dec 4;202(10):973–976. [PubMed] [Google Scholar]
  16. Mitchell J. R., Cavanaugh J. H., Arias L., Oates J. A. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest. 1970 Aug;49(8):1596–1604. doi: 10.1172/JCI106377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moody J. P., Tait A. C., Todrick A. Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry. 1967 Feb;113(495):183–193. doi: 10.1192/bjp.113.495.183. [DOI] [PubMed] [Google Scholar]
  18. Orme M., Breckenridge A., Brooks R. V. Interactions of benzodiazepines with warfarin. Br Med J. 1972 Sep 9;3(5827):611–614. doi: 10.1136/bmj.3.5827.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Prescott L. F. Drug metabolism and therapeutics. Scott Med J. 1971 Feb;16(2):121–129. doi: 10.1177/003693307101600201. [DOI] [PubMed] [Google Scholar]
  20. Sargant W. Safety of combined antidepressant drugs. Br Med J. 1971 Mar 6;1(5748):555–556. doi: 10.1136/bmj.1.5748.555-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Silverman G., Braithwaite R. A. Benzodiazepines and tricyclic antidepressant plasma levels. Br Med J. 1973 Jul 7;3(5870):18–20. doi: 10.1136/bmj.3.5870.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sjöqvist F. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc R Soc Med. 1965 Nov;58(11 Pt 2):967–978. doi: 10.1177/003591576505811P206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Skinner C., Coull D. C., Johnston A. W. Antagonism of the hypotensive action of bethanidine and debrisoquine by tricyclic antidepressants. Lancet. 1969 Sep 13;2(7620):564–566. doi: 10.1016/s0140-6736(69)90262-1. [DOI] [PubMed] [Google Scholar]
  24. Stevenson I. H., Browning M., Crooks J., O'Malley K. Changes in human drug metabolism after long-term exposure to hypnotics. Br Med J. 1972 Nov 11;4(5836):322–324. doi: 10.1136/bmj.4.5836.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Walter C. J. Clinical significance of plasma imipramine levels. Proc R Soc Med. 1971 Mar;64(3):282–285. doi: 10.1177/003591577106400322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wharton R. N., Perel J. M., Dayton P. G., Malitz S. A potential clinical use for methylphenidate with tricyclic antidepressants. Am J Psychiatry. 1971 Jun;127(12):1619–1625. doi: 10.1176/ajp.127.12.1619. [DOI] [PubMed] [Google Scholar]
  27. Willcox D. R., Gillan R., Hare E. H. Do psyhiatric out-patients take their drugs? Br Med J. 1965 Oct 2;2(5465):790–792. doi: 10.1136/bmj.2.5465.790. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES